NDC 64896-967 – Crexont
Carbidopa Hydrate 35 mg/1; Levodopa 140 mg/1 · Capsule, Extended Release · Oral
Product NDC64896-967
Product details
- Brand name
- Crexont
- Generic name
- Carbidopa and levodopa
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- Capsule, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA217186
- Marketed since
- August 9, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Aromatic Amino Acid
Active ingredients
- Carbidopa Hydrate 35 mg/1
- Levodopa 140 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 64896-967-16 | 1 BOTTLE in 1 CARTON (64896-967-16) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE | Aug 9, 2024 |
| 64896-967-23 sample | 1 BOTTLE in 1 CARTON (64896-967-23) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE | Aug 9, 2024 |
Other Crexont products
- 64896-968 Carbidopa Hydrate 52.5 mg/1; Levodopa 210 mg/1 · Capsule, Extended Release · Amneal Pharmaceuticals LLC
- 64896-969 Carbidopa Hydrate 70 mg/1; Levodopa 280 mg/1 · Capsule, Extended Release · Amneal Pharmaceuticals LLC
- 64896-970 Carbidopa Hydrate 87.5 mg/1; Levodopa 350 mg/1 · Capsule, Extended Release · Amneal Pharmaceuticals LLC